WSJ logo
Forbes logo
Fox News logo
CNN logo
Bloomberg logo
Los Angeles Times logo
Washington Post logo
The Epoch Times logo
Telemundo logo
New York Times
NY Post logo
NBC logo
Daily Beast logo
USA Today logo
Miami Herald logo
CNBC logo
Dallas News logo

FDA Premarket Approval (PMA) Review, Audit & Tips

Learn What Medical Device Manufacturers Need to Know About FDA Premarket Approval

Nick Oberheiden
Attorney Nick Oberheiden
FDA PMA Review and Audit Team Lead
Lynette Byrd
Attorney Lynette Byrd
FDA PMA Review and Audit Team Lead
Former DOJ Attorney
Attorney John Sellers
John W. Sellers
FDA PMA Review and Audit Team Lead
Former Senior DOJ Trial Attorney

The U.S. Food and Drug Administration (FDA) requires premarket approval (PMA) for new Class III medical devices. Medical device manufacturers seeking premarket approval must submit an application to the FDA, and they must provide the FDA with sufficient information to assess their devices’ safety and effectiveness. As the FDA explains:

“An approved Premarket Approval Application (PMA) . . . is, in effect, a private license granted to the applicant for marketing a particular medical device. A Class III device that fails to meet PMA requirements is considered to be adulterated under Section 501(f) of the act and cannot be marketed.”

While securing premarket approval is essential for bringing new Class III devices to market, the PMA application process is far from straightforward. To ensure that the review process goes as smoothly as possible, manufacturers submitting PMA applications must have all required safety and effectiveness data readily available, and they must be prepared to work with the FDA during its review. At Oberheiden P.C., we rely on extensive experience (including prior experience at the FDA) to manage the PMA application process for our clients, guiding them step-by-step while communicating with the FDA on their behalf.

FDA Premarket Approval Application and Pre-Market Approval Review: An Overview

The FDA premarket approval application process is complicated. There’s simply no other way to put it. As a result, an informed and structured approach is critical, and this starts with gaining a basic understanding of the major steps involved in the process:

  • Determining Whether a PMA Application is Required – The first step is determining whether a PMA application is required. As noted above, the PMA submission process is required for many (but not all) Class III medical devices. When a PMA application is not required, manufacturers can take advantage of the FDA’s more streamlined 510(k) premarket notification process.  
  • Preparing the PMA Application – Once you determine that a PMA application is required, the next step is to prepare the application. This itself is a time-intensive process that requires an in-depth understanding of all pertinent statutory and regulatory requirements. 
  • Preparing Substantiating Data and Documentation – In conjunction with preparing their PMA applications, medical device manufacturers seeking FDA approval must also prepare all necessary substantiating data and documentation. Being able to clearly demonstrate a new device’s safety and effectiveness is critical to securing FDA approval. 
  • Working with the FDA During Its Regulatory Review – After submitting their PMA applications, manufacturers should expect to work with the FDA as the FDA will begin substantive review. Answering questions and providing substantiating documentation promptly will help ensure that the process is as efficient as possible. 
  • Finalizing the Review Process and Determining Next Steps – At the end of the FDA’s review and after receiving the advisory committee report, manufacturers must determine their next steps. If the FDA approves a device, a key next step is to begin preparing for the FDA’s first postmarket inspection (discussed below). If the FDA denies approval, then manufacturers will need to work with their counsel to determine what options they have available based on the reason for the denial. 

Again, this is a broad overview of the major steps in the FDA PMA application and review process. Premarket approval applications are subject to detailed requirements; and, depending on the nature of the device, manufacturers may need to meet additional requirements as well. For example, special requirements apply to PMA applications for devices regulated by the FDA’s Center for Biologics Evaluation and Research (CBER). Our lawyers and consultants have the knowledge and experience required to assist manufacturers with the PMA process in all scenarios; and, if you have questions about submitting a PMA application to the FDA, we invite you to contact us for more information.

Put our highly experienced team on your side

Dr. Nick Oberheiden
Dr. Nick Oberheiden

Founder

Attorney-at-Law

Lynette S. Byrd
Lynette S. Byrd

Former DOJ Trial Attorney

Partner

Brian J. Kuester
Brian J. Kuester

Former U.S. Attorney

Kevin McCarthy
Hon. Kevin McCarthy

55th Speaker, U.S. House of Representatives (ret.)

Government Consultant

Mike Pompeo
Mike Pompeo

Of Counsel

Former U.S. Secretary of State

John W. Sellers
John W. Sellers

Former Senior DOJ Trial Attorney

Linda Julin McNamara
Linda Julin McNamara

Federal Appeals Attorney

Nicholas B. Johnson
Nicholas B. Johnson

Former Prosecutor

Roger Bach
Roger Bach

Former Special Agent (DOJ)

Chris Quick
Chris J. Quick

Former Special Agent (FBI & IRS-CI)

Michael S. Koslow
Michael S. Koslow

Former Supervisory Special Agent (DOD-OIG)

Ray Yuen
Ray Yuen

Former Supervisory Special Agent (FBI)

What Medical Device Manufacturers Need to Know About FDA PMA Postmarket Inspections (PMA Audits)

All medical device manufacturers that secure PMA approval are subject to PMA postmarket inspections (or PMA audits) conducted by FDA personnel. As the FDA explains:

“The PMA postmarket inspection will assess the firm’s systems, methods, and procedures for the specific devices to ensure that the firm’s quality management system is effectively established (defined, documented, and implemented) and effectively maintained. The PMA postmarket inspection should also confirm that commitments made by the firm at the time the applications were approved have been completed or are underway in accordance with those commitments.”

As a result, facing a PMA audit can be a high-risk scenario. If the FDA determines that a device manufacturer’s systems, methods, or procedures are deficient in any respect, it can impose various administrative penalties (including revocation of approval). In severe cases, failed PMA audits can lead to civil monetary penalties and other consequences as well.

5 Tips for Submitting FDA Premarket Approval Applications

With all of this in mind, what do you need to know if you are preparing to go through the FDA’s premarket approval process? Here are five tips for medical device manufacturers:

1. Start Preparing for the PMA Application Process Early

Due to the amount of work involved in preparing a PMA application for submission to the FDA, it is important to start the process early. This will help ensure that your application is ready when you are ready to file.

2. Anticipate the FDA’s Questions and Concerns

As you work with your counsel to prepare your PMA application, you should try to anticipate the FDA’s questions and concerns. The more you can do to address these proactively, the smoother the application process will go.

3. Focus on Data and Documentation

When reviewing PMA applications, the FDA focuses on data and documentation. This means that you should be focused on data and documentation, too. Securing premarket approval requires clear and comprehensiveness of a new Class III device’s safety and effectiveness.

4. Focus on the Details

Along with focusing on data and documentation, it is also important to focus on the details. When seeking premarket approval from the FDA, overlooking details can lead to a denial that could (and should) have been avoided.

5. Remember: Securing PMA Approval is Just the Start of the Process

Finally, it is important to keep in mind that securing PMA approval is just the start of the FDA compliance process. Once the FDA approves a manufacturer’s new device, the manufacturer will need to begin preparing for the FDA’s PMA audit and implement a comprehensive FDA compliance program that effectively mitigates its risk on an ongoing basis.

FAQs: FDA Premarket Approval for Class III Medical Devices

What is the difference between 510(k) and premarket approval?

The FDA’s 510(k) premarket notification process is used for medical devices that are substantially equivalent to devices that are already being (legally) marketed in the United States, while the premarket approval process is required for “new” devices that do not have substantially equivalent predicates. These processes are very different, and medical device manufacturers must ensure that they choose the correct path to obtain FDA clearance or approval.

What is the process for securing FDA premarket approval?

The process for securing FDA premarket approval starts with submitting a PMA application in accordance with the FDA’s substantive and procedural requirements. After submitting their applications, manufacturers must be prepared to work with the FDA as it evaluates the safety and effectiveness of their devices. This is a time and resource-intensive process; and, to ensure that the process goes as smoothly as possible, device manufacturers should engage experienced FDA compliance counsel to guide them forward.

How long does the FDA’s premarket approval process usually take?

Generally, medical device manufacturers should expect the FDA premarket approval process to take six months. However, the process can take significantly longer, particularly when the FDA personnel reviewing the application need to request additional information or investigate further. By carefully preparing their PMA applications in accordance with all applicable legal and regulatory requirements and anticipating reviewers’ questions and concerns, manufacturers can help ensure that the premarket approval process is as efficient as possible.

What if the FDA denies my company’s premarket approval application?

While PMA denials are relatively rare, they do happen. If the FDA denies your company’s PMA application, you will need to work with your company’s FDA compliance counsel to determine the appropriate next steps. Oftentimes, it will be possible to overcome a denial by working proactively with the FDA, and manufacturers can pursue litigation when necessary.

How can medical device manufacturers ensure compliance with the FDA’s premarket approval requirements?

Ensuring compliance with the FDA’s premarket approval requirements involves working with a team of highly experienced lawyers and consultants who can guide you through the process step-by-step. At Oberheiden P.C., our team includes former FDA personnel and federal prosecutors who have extensive experience with all aspects of FDA compliance. If you have questions about the FDA’s PMA approval process, we invite you to contact us for a complimentary consultation.


Schedule a Complimentary Consultation with an FDA Compliance Attorney at Oberheiden P.C.

If you would like to schedule a complimentary consultation with an FDA compliance attorney at Oberheiden P.C., please call 888-680-1745 or contact us online. We will arrange for you to speak with one of our senior attorneys in confidence as soon as possible.

Why Clients Trust Oberheiden P.C.

  • 2,000+ Cases Won
  • Available Nights & Weekends
  • Experienced Trial Attorneys
  • Former Department of Justice Trial Attorney
  • Former Federal Prosecutors, U.S. Attorney’s Office
  • Former Agents from FBI, OIG, DEA
  • Serving Clients Nationwide
Contact Us 888-680-1745 866-781-9539